151 related articles for article (PubMed ID: 29385795)
1. Pharmacometabonomics Analysis Reveals Serum Formate and Acetate Potentially Associated with Varying Response to Gemcitabine-Carboplatin Chemotherapy in Metastatic Breast Cancer Patients.
Jiang L; Lee SC; Ng TC
J Proteome Res; 2018 Mar; 17(3):1248-1257. PubMed ID: 29385795
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.
Chan D; Yeo WL; Tiemsim Cordero M; Wong CI; Chuah B; Soo R; Tan SH; Lim SE; Goh BC; Lee SC
Invest New Drugs; 2010 Dec; 28(6):859-65. PubMed ID: 19705063
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.
Perez EA
Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S113-6. PubMed ID: 14754468
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
Andres R; Mayordomo JI; Lara R; Lastra R; Ortega E; Polo E; Lambea J; Isla D; Saenz-Cusi A; Escudero P; Tres A
Clin Breast Cancer; 2005 Jun; 6(2):158-62. PubMed ID: 16001994
[TBL] [Abstract][Full Text] [Related]
5. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.
Sánchez-Escribano Morcuende R; Alés-Martínez JE; Aramburo González PM
Clin Transl Oncol; 2007 Jul; 9(7):459-64. PubMed ID: 17652060
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer.
Somali I; Alacacioglu A; Tarhan MO; Meydan N; Erten C; Usalp S; Yilmaz U
Chemotherapy; 2009; 55(3):155-60. PubMed ID: 19390188
[TBL] [Abstract][Full Text] [Related]
7. An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.
Awada A; Biganzoli L; Cufer T; Beex L; Lohrisch C; Batter V; Hamilton A; Nooij M; Piccart M
Eur J Cancer; 2002 Apr; 38(6):773-8. PubMed ID: 11937310
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR;
Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.
Laessig D; Stemmler HJ; Vehling-Kaiser U; Fasching PA; Melchert F; Kolbl H; Stauch M; Maubach P; Scharl A; Morack G; Meerpohl H; Weber B; Kalischefski B; Heinemann V
Oncology; 2007; 73(5-6):407-14. PubMed ID: 18515981
[TBL] [Abstract][Full Text] [Related]
10. A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients.
Frasci G; D'Aiuto G; Comella P; Thomas R; Capasso I; Botti G; Cortino GR; Di Bonito M; Rubulotta R; Vallone P; Comella G
Oncology; 2002; 62(1):25-32. PubMed ID: 11810040
[TBL] [Abstract][Full Text] [Related]
11. High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer.
Heinemann V; Stemmler HJ; Wohlrab A; Bosse D; Losem C; Kahlert S; Rauthe G
Cancer Chemother Pharmacol; 2006 May; 57(5):640-6. PubMed ID: 16163537
[TBL] [Abstract][Full Text] [Related]
12. Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
Vernieri C; Prisciandaro M; Milano M; Cona MS; Maggi C; Brambilla M; Mennitto A; Fabbroni C; Farè E; Cresta S; Celio L; Mariani G; Bianchi G; Capri G; de Braud F
Clin Breast Cancer; 2019 Apr; 19(2):e306-e318. PubMed ID: 30635175
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data.
Airoldi M; Cattel L; Passera R; Pedani F; Delprino L; Micari C
Am J Clin Oncol; 2006 Oct; 29(5):490-4. PubMed ID: 17023785
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes.
Yao G; Cao L; Liu M; Chen L; Hu X; Ye C
Chemotherapy; 2016; 61(4):171-8. PubMed ID: 26854471
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).
McCarthy N; Boyle F; Zdenkowski N; Bull J; Leong E; Simpson A; Kannourakis G; Francis PA; Chirgwin J; Abdi E; Gebski V; Veillard AS; Zannino D; Wilcken N; Reaby L; Lindsay DF; Badger HD; Forbes JF;
Breast; 2014 Apr; 23(2):142-51. PubMed ID: 24393617
[TBL] [Abstract][Full Text] [Related]
16. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R
Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Loesch D; Asmar L; McIntyre K; Doane L; Monticelli M; Paul D; Vukelja S; Orlando M; Vaughn LG; Zhan F; Boehm KA; O'Shaughnessy JA
Clin Breast Cancer; 2008 Apr; 8(2):178-86. PubMed ID: 18621615
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Modi S; Currie VE; Seidman AD; Bach AM; Panageas KS; Theodoulou M; Moasser MM; D'Andrea GM; Lake DE; Choi J; Norton L; Hudis CA
Clin Breast Cancer; 2005 Apr; 6(1):55-60. PubMed ID: 15899073
[TBL] [Abstract][Full Text] [Related]
20. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
Halim A; Wahba H
Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]